Medistim ASA (OSL:MEDI)

Medistim ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	100.15	212.09	179.21	153.87	152.64	129.49
Cash & Short-Term Investments	100.15	212.09	179.21	153.87	152.64	129.49
Cash Growth	3.94%	18.35%	16.47%	0.81%	17.88%	80.12%
Accounts Receivable	128.98	86.39	68.98	74.3	101.66	68.63
Other Receivables	1.88	10.63	10.75	9.94	8.83	4.88
Receivables	130.86	97.02	79.73	84.24	110.49	73.52
Inventory	156.46	161.13	160.52	145.39	114.33	97.41
Prepaid Expenses	-	7.48	5.64	4.67	4.55	6.08
Other Current Assets	-	0	4.04	3.39	3.88	-
Total Current Assets	387.47	477.72	429.13	391.57	385.89	306.5
Property, Plant & Equipment	81.89	79.39	71.78	57.31	51.31	58.86
Goodwill	14.13	14.13	14.13	14.13	14.13	14.13
Other Intangible Assets	87.33	71.97	46.59	31.25	21.94	16.04
Long-Term Deferred Tax Assets	11.12	9.22	9.02	5.14	3.59	3.24
Other Long-Term Assets	-0	8.18	4.32	6.33	5.79	4.48
Total Assets	581.94	660.6	574.97	505.72	482.66	403.24

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	26.63	17.73	25.08	24.47	13.21
Accrued Expenses	-	45.87	35.95	28.46	32.75	30.82
Current Portion of Leases	-	11.59	9.31	8.38	7.09	7.11
Current Income Taxes Payable	-	42.39	27.38	28.4	25.87	20.33
Other Current Liabilities	122.98	16.73	17.01	3.95	9.64	6.14
Total Current Liabilities	122.98	143.21	107.37	94.28	99.82	77.6
Long-Term Leases	34.79	37.68	25.06	9.26	10.02	17.08
Long-Term Unearned Revenue	13.16	11.31	5.93	4.23	5.13	2.51
Other Long-Term Liabilities	-	-0	-	-0	-	-0
Total Liabilities	170.93	192.19	138.36	107.78	114.97	97.19

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.59	4.59	4.59	4.59	4.59	4.59
Additional Paid-In Capital	44.17	72.74	67.66	66.6	60.59	55.2
Retained Earnings	-	368.82	328.8	307.38	285.74	240.16
Treasury Stock	-	-0.01	-0.01	-0.01	-0.02	-0.03
Comprehensive Income & Other	362.26	22.28	35.58	19.39	16.8	6.14
Shareholders' Equity	411.01	468.41	436.61	397.94	367.69	306.05
Total Liabilities & Equity	581.94	660.6	574.97	505.72	482.66	403.24

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	34.79	49.27	34.36	17.64	17.11	24.19
Net Cash (Debt)	65.36	162.82	144.85	136.23	135.54	105.3
Net Cash Growth	-12.05%	12.41%	6.33%	0.51%	28.72%	221.24%
Net Cash Per Share	3.57	8.91	7.91	7.45	7.42	5.77
Filing Date Shares Outstanding	18.29	18.28	18.31	18.28	18.25	18.23
Total Common Shares Outstanding	18.29	18.28	18.31	18.28	18.25	18.23
Working Capital	264.5	334.51	321.76	297.28	286.07	228.89
Book Value Per Share	22.47	25.62	23.84	21.77	20.14	16.79
Tangible Book Value	309.55	382.31	375.89	352.57	331.62	275.88
Tangible Book Value Per Share	16.92	20.91	20.52	19.29	18.17	15.13
Machinery	-	110.6	106.92	103.44	92.98	85.87

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error